First Fund Backs Andira Pharmaceuticals

First Fund is proud to announce its backing of Andira Pharmaceuticals, founded by Dr. Dana Lambert.

Andira is a biopharmaceutical firm leading the delivery of cannabinoid therapeutics and consumer healthcare products globally. Run by a team of biopharmaceutical industry leaders, Andira is leveraging an extensive portfolio of drug formulation and pharmaceutical delivery IP to address serious unmet needs in global healthcare. Their immediate mandates include providing solutions for the prevention and treatment of antibiotic-resistant hospital acquired infections.

“Having First Fund become a shareholder of Andira is a tremendous opportunity for our organization. This represents a keystone in our financial strategy to attract and grow together with the right venture capital partners,” remarked Dr. Dana Lambert, President and CEO of Andira.

Commenting on the partnership, First Fund founder Samarth Chandola said, “What we really like about Andira is that it’s not just another cannabis company. Instead, it’s doing cutting-edge research with cannabinoids to solve serious healthcare problems.  They are using their research on the anti-infective properties of cannabinoids to boost known, proven pharmaceuticals and healthcare products. That, along with the strength and experience of their team, gave us the confidence to jump into the foxhole with them.”